Immuneering
IMRX
IMRX
32 hedge funds and large institutions have $172M invested in Immuneering in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.36M | |
| 2 | +$1.12M | |
| 3 | +$965K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$962K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$474K |
Top Sellers
| 1 | -$6.86M | |
| 2 | -$1.7M | |
| 3 | -$1.08M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$205K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$143K |